Cencora
OnCallEpisodes
Episodes of OnCall
Mark All
Search Episodes...
In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com.
In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars.Our next
In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in
In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed.Ou
In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages.If you have any questions for our guests or have a topic you would like to lea
In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services.Our next episode will feature
In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform.Our next episode will feature information on
In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections.That's all for this episode of OnCall. Ou
In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the fiscal backdrop.Our next episode will feature information on issues regarding MPFS, Medic
In this episode, the sixth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the new DEA proposed rules on prescribing controlled substances and treatments.Our next episode will feature
In this episode, the fifth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the End of the Public Health Emergency and what it means for practices.Our next episode will feature informa
In this episode, the fourth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA.Our next episode w
In this episode, the third of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss the Inflation Reduction Act, PBM reform, and 2023 regulations.Our next episode will feature info
In this episode, the second of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss drug coverage, pricing, and payment.Our next episode will feature information on the Inflation
In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three important policy trends impacting physicians: Medicare payments, drugs/biologics, and disp
In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses consider
In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for bi
In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the difference
In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safet
In this episode, the second of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss the history of biosimilars, the reception o
In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss what biosimilars are (and aren’t), interchan
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the importance of
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the advantages and
In this podcast series brought to you by Invitae, oncology specialists who routinely integrate genetic information into their patients' treatment, discuss actionable options for implementing genomics-informed, personalized cancer care.In the fi
In the final episode of our buy and bill series, we discuss reducing financial barriers for your patients and talk to Joe Baffone, CEO of Annexus Health, about the benefit of implementing efficient financial navigation programs within your prac
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us